Arcellx Files 8-K on Security Holder Votes
Ticker: ACLX · Form: 8-K · Filed: May 28, 2025 · CIK: 1786205
| Field | Detail |
|---|---|
| Company | Arcellx, INC. (ACLX) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Arcellx held a shareholder vote, details to follow.
AI Summary
Arcellx, Inc. filed an 8-K on May 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the vote outcomes or the proposals presented.
Why It Matters
This filing indicates Arcellx held a vote of its security holders, which could pertain to important corporate governance matters or strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial or operational risks.
Key Players & Entities
- Arcellx, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of Report
FAQ
What specific matters were submitted for a vote by Arcellx's security holders?
The filing does not specify the exact proposals or matters that were submitted for a vote.
When was the date of the earliest event reported in this 8-K?
The date of the earliest event reported is May 28, 2025.
What is Arcellx, Inc.'s principal executive office address?
Arcellx, Inc.'s principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.
What is the SIC code for Arcellx, Inc.?
The Standard Industrial Classification (SIC) code for Arcellx, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Is this filing intended to satisfy any other reporting obligations simultaneously?
The filing notes that it is not intended to simultaneously satisfy the filing obligations under any other provisions of the Securities Exchange Act of 1934, as indicated by the unchecked box.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Arcellx, Inc. (ACLX).